WHEN NATIONAL STEREOTYPES BECOME A BRAND: THE CASE OF SPAIN’S DESTINATION MARKETING
, 2021 Miriam Soriano Procas +1 more
openalex +2 more sources
Molecular Oncology, EarlyView.The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Can the Introduction of Live Streaming E-commerce Rescue Troubled Domestic Brands? A Case Study of Chinese National Brands [PDF]
You Liliang
openalex +1 more source
LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro
Molecular Oncology, EarlyView.Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix +13 more
wiley +1 more source
Research on the Art Brand Building Mechanism of National Musical Venue
, 2020 Jie-Yu FU
openalex +1 more source
Market Analysis for “Naga Minerals “ and It Competitions Over National and Regional Brands
, 2023 A. Jayanthi, R. Arunkumar
openalex +1 more source
Advances in National Brand and Private Label Marketing [PDF]
, 2023 Juan Carlos Gázquez-Abad +2 more
openalex +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Brand switching and toxic chemicals in cigarette smoke: A national study
, 2018 Jennifer Mendel Sheldon +8 more
openalex +2 more sources
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
Molecular Oncology, EarlyView.We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source